Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 12:22 PM
Ignite Modification Date:
2025-12-25 @ 12:03 PM
NCT ID:
NCT01702961
Group ID:
EG000
Title:
Rituxan+BEAM: Autologous Stem Cell Transplant
Description:
Ara-C, VP-16, BCNU, Melphalan, Rituxan and Stem Cells BEAM Conditioning.
BEAM Conditioning.
Melphalan: Given on Day -1
Melphalan is administered according to the current SOP.
Ara-C: 200 mg/m2 IB BID given on Days -5, -4, -3, -2
VP-16: 200 mg/m2 IV BID given on Days -5, -4, -3, -2
BCNU: BCNU 300 mg/m2 IV given on Day -6
Rituxan: 375 mg/m2 IB given on Days -6, +14, +21, +28
Stem Cells: Stem cells given on Day 0
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
1
Serious Number At Risk:
75
Other Number Affected:
2
Other Number At Risk:
75
Study:
NCT01702961
Results Section:
NCT01702961
Adverse Events Module:
NCT01702961